ClinicalTrials.gg
CompletedNCT01009151Updated May 27, 2015

Heart Failure Patient Self-Management Web Portal Pilot Study

An interventional study of Heart Self Care Tracker and Heart Care Self Tracker in Congestive Heart Failure, sponsored by University of Michigan. Completed at 1 site in United States. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2015-05-27.

Sponsored by University of Michigan · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
43
Allocation
Not applicable
Ages
19 Years and older
Sex
All
01

Study summary

The proposed pilot project is aimed at assessing the feasibility, acceptability and impact of a web-based home tele-monitoring system among congestive heart failure patients at the University of Michigan Health System. The intervention consists of daily reporting via the internet on health parameters, such as weight, blood pressure, heart rate and heart failure symptoms. In addition to symptom and data reporting, the system provides links to educational material on heart failure and reminders for self-care measures. It is designed as an inexpensive, user-friendly, and clinically effective system.

Each patient will be provided with a unique name and password, and will be instructed on how to use the self-management website.

The proposed home monitoring system study holds the potential to improve the lives of heart failure patients treated at the University of Michigan Health System by empowering them to participate actively in their care and to reduce the risk of hospitalization. As heart failure represents the most common hospital diagnosis related group (DRG)among the elderly, this study offers a significant public health benefit.

Read the detailed description

The study will be based on a sample of 25 heart failure patients enrolled with the UMHS Heart Failure Program who give informed consent to participate in the study. The clinical protocols and electronic software were developed by the UMHS-CVC Heart Failure Program in collaboration with the UMHS Telemedicine Resource Center. These protocols contain automated trigger mechanisms when certain values are exceeded to alert the provider and the patient for the need to take appropriate remedial action.

The UMHS Heart Failure Disease Management Program contains a registry of more than 3000 patients with heart failure problems. Currently, a multidisciplinary nursing team maintains routine contacts with these patients through telephone calls and paper records. The program has been acknowledged for its adherence to quality of care measures, and was the first to be awarded accreditation by JCAHO for ambulatory heart failure care. Despite its relative success, patients continue to be at high risk for re-hospitalization due to worsened heart function. The proposed tele-monitoring system is expected to reduce the need for re-hospitalization and to improve health outcomes by virtue of automated daily reporting and greater patient involvement in self-management. Because of its high promise, this area of research has been receiving increased attention, but so far without definitive results. Previous research has provided evidence of reduced emergency room visits and hospitalizations, improved patient compliance with care and overall cost containment among high-risk patient populations. But the studies relied on relatively expensive systems involving specialized hardware and proprietary software. The cost of these interventions presents a limitation to the broad adoption and use of the technology. The proposed project is an attempt to ascertain the optimal method from a clinical and cost standpoint for in-home telemonitoring for this large patient population that is likely to grow with the aging of the population.

The primary end-points of this pilot are: (1) patient willingness to use the system, perceptions regarding its efficacy and effectiveness and problems encountered in its use; (2) patient adherence to heart failure-specific self care practices; (3) patient health literacy and quality of life; and (4) provider perceptions of the efficacy and effectiveness of the system and problems encountered in its use.

The findings should be helpful in refining the clinical protocols and data management algorithms and establishing a solid foundation for large-scale randomized clinical trials for obtaining the necessary evidence for wide-scale adoption of these systems in the United States and elsewhere.

02

Conditions studied

  • Congestive Heart Failure

Browse trials for

Keywords

  • telemonitoring
  • internet
  • home monitoring system
  • heart failure
  • self management plan
  • web portal
03

In context

Heart Failure

5,803 studies on the registry are indexed under Heart Failure; 1,222 are open to participants now.

This study's enrollment of 43 is below the median of 72 across 3,790 interventional studies indexed under Heart Failure.

Browse Heart Failure studies →

Lead sponsor

University of Michigan is the lead sponsor of 1,503 studies on the registry; 189 are open to participants now.

Of its 167 completed or terminated interventional studies of FDA-regulated products, 132 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • Inclusion criteria

    1. Clinical diagnosis of heart failure with NYHA II-IV symptoms, or evidence of at least one heart failure hospitalization within the past 12 months.
    2. Provider permission to approach patient for enrollment
    3. Willingness to sign informed consent

Exclusion Criteria:

  • Exclusion criteria include patients who are

    1. Under the age of 19
    2. Asymptomatic heart failure
    3. Prisoners
    4. Residents of long term nursing facilities
    5. Receiving dialysis
    6. Serum creatinine ≥ 3.5 mg/dL
    7. Candidates for revascularization
    8. Candidates for valve replacement or repair
    9. With comorbidity (i.e. metastatic cancer) that is likely to lead to rehospitalization or death within a 12 month period
    10. Due to a reversible cause (i.e. hypothyroidism, anemia, etc)
    11. With pulmonary arterial hypertension that is not due to left ventricular dysfunction.
    12. Pregnant women or women of child bearing potential who are actively attempting to become pregnant or are not using an accepted form of contraception
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
43 participants (actual)

Study arms

  • Experimental
    Heart Care Self Tracker

    Web-based Home Tele-monitoring system

    Behavioral: Heart Self Care Tracker · Behavioral: Heart Care Self Tracker

Interventions

  • BehavioralHeart Self Care Tracker

    Web-based home tele-monitoring system serving congestive heart failure patients at the University of Michigan Health System. The intervention consists of daily reporting via the Internet on parameters specified in clinical protocols, including weight, blood pressure, heart rate and heart failure symptoms. These protocols contain automated trigger mechanisms when certain values are exceeded to alert the provider and the patient for the need to take appropriate remedial action. The system provides links to educational material on heart failure and reminders for self-care measures.

    Also known as: web-based self-management system, web portal

  • BehavioralHeart Care Self Tracker

    Web-based Home Tele-monitoring System

06

What researchers measure

Primary outcomes

  1. Patient adherence to heart failure-specific self care practices, as measured by the self-care practices score.

    Time frame: 12 weeks

Secondary outcomes

  1. Patient satisfaction and perceptions regarding utility and acceptability of the system.

    Time frame: 12 weeks

07

Study locations

1 site
  • University of Michigan Cardiovascular Center
    Ann Arbor, Michigan 48109, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 27, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01009151
Responsible party
Todd M. Koelling, M.D. (Associate Professor, University of Michigan) — Principal investigator
First posted
Nov 6, 2009
Start date
Nov 2009
Primary completion
Jan 2012
Completion
Jan 2012
Last update
May 27, 2015

Study contacts

Todd M Koelling, M.D.
principal investigator · University of Michigan

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion